Jane Street’s Creative Medical Technology CELZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,205
Closed -$59.2K 11701
2025
Q4
$59.2K Buy
+30,205
New +$89.3K ﹤0.01% 10449
2022
Q1
Sell
-6,220
Closed -$137K 10335
2021
Q4
$137K Buy
+6,220
New +$130K ﹤0.01% 9062

Other funds holding CELZ

Jane Street's CELZ Position: Q1 2026 in Review

Jane Street sold out of Creative Medical Technology (CELZ) in Q1 2026, closing a stake of 30,205 shares — an estimated $59.2K sold.

Jane Street first reported a position in CELZ in Q4 2021 and held it in 2 quarters. The position peaked at $137K in Q4 2021. 11 funds tracked by Wall St. Rank hold CELZ as of Q1 2026.

  • Jane Street reported no remaining Creative Medical Technology position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 30,205 Creative Medical Technology shares in Q1 2026, an estimated $59.2K.
  • Jane Street first reported a position in Creative Medical Technology in Q4 2021 and held it in 2 quarters.
  • Jane Street's Creative Medical Technology position peaked at $137K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.